Orexigen Therapeutics

Latest Orexigen Therapeutics News

1. 
   Makers of Obesity Pills Again Try to Win FDA Approval

   Fri, 16 Sep 2011

   frontal assault on the FDA. Orexigen Therapeutics said it was appealing the agency benefits. Vivus, Arena, and Orexigen received so-called complete Contrave Trial The agency told Orexigen in late January that it needed
2. Quiksilver, DryShips, Tesla Motors Are Big Movers

   Fri, 3 Jun 2011

   maker is selling 5.3 million shares to the public, raising money to develop its Model X crossover vehicle. Orexigen Therapeutics Inc ., down $1.06 at $2.12 The drugmaker put on hold further work to secure U.S. approval for its obesity
3. Orexigen Puts Obesity Drug Development on Hold

   Fri, 3 Jun 2011

   regulators on safety trials. Orexigen Therapeutics Inc . said Friday that it will focus announcement indicated that Orexigen believes Contrave's prospects pharmaceutical market. Shares of Orexigen tumbled $1.03, or 32.3
4. 
   FDA Panel Supports New Diet Pill After Rejecting Two Others

   Thu, 9 Dec 2010

   panel's action reasonable given the oversized costs and health burdens of obesity. Contrave, developed by Orexigen Therapeutics of La Jolla, Calif., would be used by men and women with a body mass index of at least 30, or 27 if they also
5. 
   11 Medical Weight Loss Treatments Examined

   Tue, 21 Jul 2009

   the medications and procedures that have made headlines in recent years. Contrave What is it? On Monday , Orexigen Therapeutics , Inc ., the makers of Contrave, announced that they had completed clinical trials for the weight loss drug. In
6. 
   New Diet Drug Attacks Craving Center

   Mon, 20 Jul 2009

   the craving issue," said Dr. Dennis Kim, senior vice president of medical affairs and communications at Orexigen Therapeutics Inc ., maker of Contrave. "We have clearly cleared the hurdle, the efficacy benchmark, it's of course the